exhibit

signal

Boston Properties, Inc.

Owned by BXP (NYSE: BXP), the world-class observatory, designed with the adventurer in mind, features state-of-the-art immersive experiential exhibits, 360° breathtaking views of the city, and more.

We alerted the SELL signal at $54.34 and we were able to close this one with profit at $53.51 🥳

We alerted the BUY signal at $52.1 and we were able to close this one with profit at $54.85 🔏

We alerted the SELL signal at $57.52 and we were able to close this one with profit at $53.43 ✅

We alerted the BUY signal at $66.21 and we were able to close this one with profit at $66.18 ✅

$SHOP $OKTA $BXP   
Bullish trade signals have been generated!

$BXP  
 
 Signal Update  
 
 As of today, BXP is up +3.77 percent from buy price 72.29 in 8days and on track to achieve target price 75.71.

$BXP  
 
 Signal Update  
 
 As of today, BXP is up +2.55 percent from buy price 72.29 in 8days and on track to achieve target price 75.71.

$BXP $F $COO   
Bullish trade signals have been generated!

company

Buy slowly and patiently in good companies. Cheers!

BXP Maintains Industry Leadership, Improves Ranking in Newsweek’s List of the Most Responsible Companies For 2023 https://conferencecalltranscripts.com/summary/?id=483590&amp;pr=true $BXP

BXP Maintains Industry Leadership, Improves Ranking in Newsweek’s List of the Most Responsible Companies For 2023 https://conferencecalltranscripts.com/summary/?id=483589&amp;pr=true $BXP

$BXP https://www.stockilluminati.com/bxp/news.php - BXP Maintains Industry Leadership, Improves Ranking in Newsweek’s List of the Most Responsible Companies For 2023

$BXP BXP Maintains Industry Leadership, Improves Ranking in Newsweek’s List of the Most Responsible Companies For 2023
https://www.stocktitan.net/news/BXP/bxp-maintains-industry-leadership-improves-ranking-in-newsweek-s-ae2ju206lug6.html

BXP ranked first in the Real Estate &amp; Housing industry with an increased ranking of 29th overall out of the 500 companies included and had the third highest environmental score.

industry

price

Madrigal Pharmaceuticals Inc

data

$CACO Perhaps the biggest kick in the nuts is seeing this garbage $MDGL hit all time highs yesterday at $315 after reporting NASH data.

$MDGL as good as the phase 3 data was this is fuckin nuts and the manipulation couldn&#39;t be more blatant.

Data is not even as good as some competitors

$MDGL So many irregularities with the data.

$MDGL if you look at the data closer, it is actually a disgused failure.

This market is a shit show that wants to collapse and any bad data this will get eviscerated!

The data is dropping with an 830am eastern time conference call.

Leaving data to last possible minute isn’t a good sign.

market

$MDGL this stock market is so full of shit.

$MDGL $VKTX markets going up and this aint.

Suddenly you realize the market is not as big as they are claiming!

$MDGL This is a perfect example of what is wrong with this market still.

show

$MDGL Today is going to be an absolute shit show likely with markets tanking and no news here.

strike

suck

$MDGL For all the mean and rude assholes out there.

WTF Jerry even the neighborhood asshole can be civil.

$MDGL down down down let’s go bears fuck this piece of crap

$MDGL a lot of options for tomorrow are being fucked with.

We alerted the SELL signal at $239.51 and we were able to close this one with profit at $238.81 💯

We alerted the SELL signal at $262.53 and we were able to close this one with profit at $255.825 🔏

We alerted the SELL signal at $271.83 and we were able to close this one with profit at $270.93 📊

We alerted the SELL signal at $269.19 and we were able to close this one with profit at $272.3 🎲

We alerted the SELL signal at $276.84 and we were able to close this one with profit at $272.73 ✅

100% accuracy based on 5 signals. https://pbs.twimg.com

This will go beyond parabolic on good data … literally no shares out there unless they offer new ones … $MDGL $VKTX $SLS $SAVA

I don’t have to wait for fda approval for such low MC like ETNB is good promising data in next 3 weeks .. it can 3x my investments .. like AKRO is seating at 2B… ETNB HAS a strong potential for 2-3x from here next 3-4 weeks

This is an outstanding setup for $VKTX&#39;s VK2809 P2b study which is scheduled to release data in Q2 2023.

Well for genius shorts who can&#39;t read medical data, this is a GREAT shorting opportunity.

$VKTX from what I&#39;ve read from the preliminary trial data, the molecule is good, maybe better than $MDGL and has applications in weightloss.

$MDGL $ALT $TERN will wind up better with much better data.

With slam-dunk efficacy data and two years worth of safety data with no significant adverse safety events reported, Resmetirom has a clear path forward to accelerated approval.

$MDGL their PhIII data are so resoundingly positive that this has been termed a “watershed moment” and a “shock win” for the company.

bull

$MDGL cheers bulls great finish to the year!

$MDGL congrats to all longs and bulls here.

$MDGL benefits of owning low float market king bull.

$MDGL  
The MM now  
ok guys we did a great job this week let&#39;s celebrate Christmas and enjoy the fool&#39;s bulls&#39; money

$MDGL The horns on this bull are massive.

$MDGL - Congrats bulls on MDGL&#39;s stellar P3 performance and strong price run especially leading up to the holidays.

trial

$MDGL this is the cream of the crop, we already have stellar phase 3 results in the books.

$MDGL nice opportunity to add a few hundred shares here 😆  the celebration of shorts today reminded me when the stock price dropped sharply by 27% in a couple of days before trial readout.

Based on my multi year knowledge in NASH field, mdgl management so far did the best execution of clinical development - too many things to exemplify here!

Study results showed statistically significant absolute reductions in hepatic fat fraction at week 13 with pegozafermin administered every week or every two weeks compared to placebo.

After reaching its endpoints on its Phase 3 data we have seen a $240 spike!

Plus, remember this company is light years ahead of its competitors none of whom have had success with Phase 3. Bullish!

$VKTX Truth: VKTX increased more than 100% last 3 days since $MDGL has Phase 3 results.

Fifth Third Bancorp

shit

$FITB Boosted the stock up out of no where keep blowing your own millions to make it look like everything is ok… Sick fuck

$FITB So one of the owners buys 1.3 million of itself just to try and make it look like the company is not failing.. That was some bitch made punk ass shit

The event is one of the nation’s largest outdoor light and art festivals known for its immersive exhibits and experiences and will return to Cincinnati Oct. 13-16, 2022.

We alerted the BUY signal at $25.73 and we were able to close this one with profit at $26.21 🎲

When sentiment gets stupid ugly, it’s a buy signal for me.

bank

$FITB not to mention bond yields have dropped drastically which will help banks HTM portfolio. .

$FITB quality +dividend+int rate pause = stronger bank new business from mortgages and car loans at lower rates near term

$FITB $WAL $SCHW invest in robust bank these are great and reward will be huge.

$FITB Solid bank with good dividend 🤔 I’m in at these levels.

$KEY $FITB 2 of the best ran regional banks.

$FITB NEW ARTICLE : I am exceptionally comfortable with the position we got, says Fifth Third Bank CEO Timothy Spence https://www.stck.pro/news/FITB/44421363

If you are playing regional banks these two are good ones to have.

Top Stocks matching your search for "exhibit signal"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

BXP

Boston Properties, Inc.

-31.61%

$73.04 - $49.95

Oct, 5, 2022

MDGL

Madrigal Pharmaceuticals Inc

-10.68%

$275.00 - $245.64

Dec, 20, 2022

FITB

Fifth Third Bancorp

-27.54%

$37.80 - $27.39

Sep, 29, 2022

BXP

Boston Properties, Inc.

-31.61%

$73.04 - $49.95

MDGL

Madrigal Pharmaceuticals Inc

-10.68%

$275.00 - $245.64

Dec, 20, 2022

FITB

Fifth Third Bancorp

-27.54%

$37.80 - $27.39

Sep, 29, 2022